Kura Oncology (KURA) News Today $8.07 +0.21 (+2.67%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$8.05 -0.02 (-0.20%) As of 08/28/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KURA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Kura Oncology to Participate in Three Upcoming Investor ConferencesAugust 28 at 7:30 AM | globenewswire.comKura Oncology, Inc. $KURA Shares Purchased by Russell Investments Group Ltd.August 28 at 3:37 AM | marketbeat.comAlethea Capital Management LLC Raises Holdings in Kura Oncology, Inc. $KURAAugust 23, 2025 | marketbeat.comKura Oncology, Inc. $KURA Shares Bought by Algert Global LLCAugust 20, 2025 | marketbeat.comWall Street Zen Upgrades Kura Oncology (NASDAQ:KURA) to "Hold"August 18, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Shares Gap Up - Here's WhyAugust 17, 2025 | marketbeat.comKura Oncology Inc. (KURA) Stock Price Today - WSJAugust 16, 2025 | wsj.comKura Oncology (NASDAQ:KURA) Trading Up 10.7% - What's Next?August 14, 2025 | marketbeat.comKura Oncology’s Earnings Call: Progress Amidst ChallengesAugust 13, 2025 | msn.comKura Oncology (NASDAQ:KURA) Price Target Cut to $24.00 by Analysts at JMP SecuritiesAugust 12, 2025 | marketbeat.comWedbush Issues Negative Estimate for Kura Oncology EarningsAugust 12, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Given Consensus Rating of "Moderate Buy" by BrokeragesAugust 12, 2025 | marketbeat.comKura Oncology price target lowered to $27 from $29 at BofAAugust 11, 2025 | msn.comKura Oncology, Inc. (NASDAQ:KURA) Just Reported And Analysts Have Been Cutting Their EstimatesAugust 10, 2025 | uk.finance.yahoo.comKura Oncology (NASDAQ:KURA) Cut to "Sell" at Wall Street ZenAugust 10, 2025 | marketbeat.comKura Oncology, Inc. (KURA) Q2 2025 Earnings Call TranscriptAugust 9, 2025 | seekingalpha.comKura (KURA) Revenue Drops 61%August 7, 2025 | fool.comKura Oncology Reports Second Quarter 2025 Financial ResultsAugust 7, 2025 | globenewswire.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 4, 2025 | globenewswire.comKura Oncology to Report Second Quarter 2025 Financial ResultsJuly 31, 2025 | globenewswire.comKura Oncology Inc. Company & People | KURA | Barron'sJuly 30, 2025 | barrons.com1492 Capital Management LLC Acquires 87,148 Shares of Kura Oncology, Inc. (NASDAQ:KURA)July 24, 2025 | marketbeat.comJennison Associates LLC Boosts Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)July 22, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJuly 18, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Stock Crosses Below 200-Day Moving Average - Should You Sell?July 10, 2025 | marketbeat.comKura Oncology Grants Stock Options to New Employees Under 2023 Inducement Option Plan - NasdaqJuly 5, 2025 | nasdaq.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 3, 2025 | globenewswire.comKura Oncology and Kyowa Kirin enter agreement to co-promote leukemia drug in US - Investing.comJuly 2, 2025 | investing.comKura Oncology's (KURA) Overweight Rating Reaffirmed at Cantor FitzgeraldJune 26, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of "Moderate Buy" by AnalystsJune 23, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Receives "Outperform" Rating from WedbushJune 20, 2025 | marketbeat.comKura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlookJune 15, 2025 | investing.comKura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association CongressJune 12, 2025 | globenewswire.comLightning Round: 'Wait and see situation' with Papa John's, says Jim CramerJune 12, 2025 | msn.comBrokers Issue Forecasts for Kura Oncology FY2026 EarningsJune 10, 2025 | marketbeat.comKura Oncology Grants Stock Options To New Hires Under Inducement PlanJune 7, 2025 | nasdaq.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | globenewswire.comJMP Securities Reiterates "Market Outperform" Rating for Kura Oncology (NASDAQ:KURA)June 4, 2025 | marketbeat.comTwo Sigma Investments LP Sells 42,120 Shares of Kura Oncology, Inc. (NASDAQ:KURA)June 4, 2025 | marketbeat.comNuveen Asset Management LLC Lowers Stock Position in Kura Oncology, Inc. (NASDAQ:KURA)June 4, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Shares Gap Up - What's Next?June 3, 2025 | marketbeat.comASCO25: Kura’s Phase II ziftomenib results trigger NDA acceptance from FDAJune 3, 2025 | finance.yahoo.comKura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual MeetingJune 2, 2025 | globenewswire.comFDA Grants Priority Review for Kura Oncology, Inc. (KURA) and Kyowa Kirin’s ZiftomenibJune 2, 2025 | insidermonkey.comSquarepoint Ops LLC Takes $799,000 Position in Kura Oncology, Inc. (NASDAQ:KURA)June 2, 2025 | marketbeat.comKura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AMLJune 1, 2025 | globenewswire.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Two Sigma Advisers LPMay 30, 2025 | marketbeat.comKura Oncology at TD Cowen Summit: Strategic Innovations in Menin InhibitorsMay 29, 2025 | uk.investing.comCantor Fitzgerald maintains Overweight on Kura Oncology stockMay 26, 2025 | uk.investing.comKura Oncology (NASDAQ:KURA) Trading Down 4.7% - What's Next?May 25, 2025 | marketbeat.com Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KURA Media Mentions By Week KURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼1.481.03▲Average Medical News Sentiment KURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼46▲KURA Articles Average Week Get the Latest News and Ratings for KURA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Kura Oncology and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CPRX News ALVO News KNSA News OGN News TARS News CNTA News DNLI News AGIO News IDYA News IBRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access